मुख्य सामग्री पर जाएं
अनुवाद जारी है — आपकी भाषा का संस्करण तैयार होने तक यह सामग्री अंग्रेज़ी में दिखाई जा रही है।
चर्चाओं पर वापस जाएं

Meet the under-35s shaping the future of biotech

Healthcare
वैश्विक
September 12, 2026 को शुरू किया गया

Every year, MIT Technology Review puts together a list of some of the brightest and best young minds working across science and technology. Our 35 Innovators Under 35 are the ones to watch—people whose research and technical work stands to shape the future of their fields. This year, the list includes nine people who are…

स्रोत लेख

कथन जोड़ें विश्लेषण 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 मतदान के लिए कथन • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Young biotech innovators should prioritize disease treatments that serve wealthy markets over rare diseases affecting poor populations.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Under-35s in biotech may prioritize profit over public health in their innovations.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
The achievements of young innovators in biotech should be widely celebrated to encourage further innovation.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Public funding for biotech should be allocated based on project promise, not on lists of celebrated names or ages.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Breakthrough biotech discoveries should be evaluated by their scientific merit and potential impact, not the age or background of the researcher.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Biotech education programs should heavily feature the work of young innovators to inspire future generations.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Public support for biotech research should include initiatives led by under-35s.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Regulatory agencies should streamline approval pathways for therapies developed by younger researchers to accelerate time-to-patient.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
The contributions of under-35s in biotech will likely lead to significant ethical dilemmas.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results
CLAIM द्वारा पोस्ट admin • Sep 12, 2026
Biotech innovation leadership should reflect the demographic diversity of the populations whose health outcomes depend on new discoveries.

अनुवाद लंबित है

Vote options for this statement: agree, disagree, or unsure
💬 चर्चा देखें
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us